# The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study

> **NCT01622777** · PHASE2 · COMPLETED · sponsor: **Alejandra Guillermina Miranda Diaz** · enrollment: 34 (actual)

## Conditions studied

- Diabetic Polyneuropathy

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01622777
- **Lead sponsor:** Alejandra Guillermina Miranda Diaz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-01
- **Final completion:** 2011-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01622777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01622777, "The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01622777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*